Data / Drug companies / Serotonin-1b and Serotonin-1d Receptor Agonist
Serotonin-1b and Serotonin-1d Receptor Agonist drugs: 15 drugs from 82 companies in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Serotonin-1b and Serotonin-1d Receptor Agonist is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 281 products in this class from 82 companies, covering 15 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on June 1, 2026.
The request: Get every company that lists a Serotonin-1b and Serotonin-1d Receptor Agonist drug in the FDA NDC directory, with headquarters, website and size. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 82Companies
- 281Products
- 15Drugs by generic name
Drugs in the Serotonin-1b and Serotonin-1d Receptor Agonist class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Sumatriptan | 53 | 28 |
| Rizatriptan benzoate | 65 | 25 |
| Sumatriptan succinate | 65 | 24 |
| Zolmitriptan | 46 | 22 |
| Eletriptan hydrobromide | 19 | 11 |
| Naratriptan | 8 | 4 |
| Frovatriptan succinate | 4 | 4 |
| Rizatriptan | 5 | 3 |
| Sumatriptan and naproxen sodium | 3 | 3 |
| Almotriptan | 4 | 2 |
| Sumatriptan succinate and naproxen sodium | 2 | 2 |
| Almotriptan malate | 2 | 1 |
| Eletriptan hbr | 2 | 1 |
| Rizatriptan benzoate odt | 2 | 1 |
| Meloxicam, rizatriptan | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Direct_Rx | 14 | tablet, film coated; tablet | Generic drugs (ANDA) | January 20, 2025 |
| A-S Medication Solutions | 12 | tablet; tablet, film coated | Generic drugs (ANDA) | April 27, 2026 |
| Bryant Ranch Prepack | 11 | tablet; tablet, film coated | Generic drugs (ANDA) | November 16, 2021 |
| Aurobindo Pharma Limited | 10 | tablet; tablet, film coated | Generic drugs (ANDA) | February 15, 2018 |
| Glenmark Pharmaceuticals Inc., USA | 9 | tablet, orally disintegrating; tablet, film coated | Generic drugs (ANDA) | March 11, 2016 |
| NuCare Pharmaceuticals,Inc. | 9 | tablet; tablet, film coated | Generic drugs (ANDA) | February 18, 2022 |
| Asclemed USA, Inc. | 8 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | May 31, 2016 |
| Golden State Medical Supply, Inc. | 8 | tablet, film coated; tablet, orally disintegrating | Generic drugs (ANDA) | July 1, 2013 |
| Proficient Rx LP | 8 | tablet | Generic drugs (ANDA) | November 17, 2009 |
| Bionpharma Inc. | 7 | tablet, film coated; tablet, orally disintegrating | Generic drugs (ANDA) | April 11, 2022 |
| Mylan Pharmaceuticals Inc. | 7 | tablet, film coated | Generic drugs (ANDA) | August 15, 2017 |
| Advanced Rx of Tennessee, LLC | 6 | tablet, film coated; tablet | Generic drugs (ANDA) | October 15, 2025 |
| Alembic Pharmaceuticals Inc. | 6 | tablet, film coated; injection | Generic drugs (ANDA) | November 6, 2025 |
| Alembic Pharmaceuticals Limited | 6 | tablet, orally disintegrating; tablet, film coated | Generic drugs (ANDA) | November 6, 2025 |
| GlaxoSmithKline LLC | 6 | tablet, film coated; injection | New drug applications (NDA) | April 6, 2006 |
| Proficient Rx LP | 6 | tablet, film coated; tablet, orally disintegrating | Generic drugs (ANDA) | March 7, 2017 |
| Teva Pharmaceuticals USA, Inc. | 6 | tablet, film coated; tablet | Generic drugs (ANDA) | July 21, 2017 |
| Cipla USA Inc. | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | February 22, 2021 |
| Preferred Pharmaceuticals Inc. | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | March 29, 2024 |
| Sportpharm LLC | 5 | tablet; injection | Generic drugs (ANDA) | April 20, 2023 |
| Ajanta Pharma USA Inc. | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | May 31, 2016 |
| Bryant Ranch Prepack | 4 | spray; tablet, film coated | Generic drugs (ANDA) | November 16, 2021 |
| Dr. Reddy's Laboratories Limited | 4 | tablet; injection | Generic drugs (ANDA) | February 24, 2014 |
| Macleods Pharmaceuticals Limited | 4 | tablet, film coated; tablet, orally disintegrating | Generic drugs (ANDA) | September 23, 2014 |
| NorthStar Rx LLC | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | November 27, 2018 |
| Onesource Specialty Pharma Limited | 4 | injection, solution | Generic drugs (ANDA) | February 2, 2026 |
| Rising Pharma Holdings, Inc. | 4 | tablet, orally disintegrating; tablet | Generic drugs (ANDA) | July 1, 2013 |
| Unichem Pharmaceuticals (USA), Inc. | 4 | tablet, orally disintegrating; tablet | Generic drugs (ANDA) | March 7, 2017 |
| Zydus Pharmaceuticals USA Inc. | 4 | tablet, orally disintegrating; tablet, film coated | Generic drugs (ANDA) | July 12, 2017 |
| Amneal Pharmaceuticals NY LLC | 3 | spray, metered; tablet, film coated | Authorized generics (NDA) | July 15, 2024 |
| Padagis Israel Pharmaceuticals Ltd | 3 | spray | Generic drugs (ANDA) | November 16, 2021 |
| Rising Pharma Holdings, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | May 5, 2025 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | August 10, 2009 |
| Amneal Pharmaceuticals LLC | 2 | tablet, film coated | Generic drugs (ANDA) | January 9, 2023 |
| Apnar Pharma LP | 2 | tablet, film coated | Generic drugs (ANDA) | May 13, 2026 |
| Ascend Laboratories, LLC | 2 | tablet | Generic drugs (ANDA) | June 25, 2012 |
| Asclemed USA Inc. | 2 | tablet | Generic drugs (ANDA) | March 15, 2011 |
| Aurobindo Pharma Limited | 2 | tablet, film coated | Generic drugs (ANDA) | January 15, 2019 |
| AvKARE | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | September 17, 2025 |
| BluePoint Laboratories | 2 | tablet, film coated | Generic drugs (ANDA) | March 13, 2014 |
| Camber Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 7, 2025 |
| Chartwell RX, LLC | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | July 1, 2013 |
| Creekwood Pharmaceuticals LLC | 2 | tablet | Generic drugs (ANDA) | December 31, 2012 |
| Direct RX | 2 | tablet | Generic drugs (ANDA) | April 22, 2019 |
| Eugia US LLC | 2 | injection, solution | Generic drugs (ANDA) | April 23, 2013 |
| Gensco Laboratories LLC | 2 | film | New drug applications (NDA) | April 27, 2026 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | March 15, 2011 |
| Hikma Pharmaceuticals USA Inc. | 2 | tablet | Generic drugs (ANDA) | July 7, 2010 |
| Jubilant Cadista Pharmaceuticals Inc. | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | September 17, 2015 |
| Lannett Company, Inc. | 2 | spray | Generic drugs (ANDA) | February 19, 2016 |
| Medstone Pharma LLC | 2 | tablet, film coated | Generic drugs (ANDA) | May 30, 2018 |
| Organon LLC | 2 | tablet; tablet, orally disintegrating | New drug applications (NDA) | June 1, 2021 |
| PLD Acquisitions LLC DBA Avma Pharma Solutions | 2 | tablet, film coated | Generic drugs (ANDA) | February 27, 2017 |
| Panacea Biotec Limited | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | January 17, 2017 |
| Prasco Laboratories | 2 | spray | Authorized generics (NDA) | July 1, 2020 |
| Proficient Rx LP | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | February 18, 2022 |
| Remedyrepack Inc. | 2 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | June 18, 2025 |
| Rising Pharma Holdings, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | May 11, 2016 |
| Sun Pharmaceutical Industries, Inc. | 2 | injection; tablet, film coated | Generic drugs (ANDA) | August 20, 2025 |
| Tonix Medicines, Inc. | 2 | solution; spray | New drug applications (NDA) | July 1, 2023 |
| Viatris Specialty LLC | 2 | tablet | New drug applications (NDA) | May 8, 2025 |
| Zydus Lifesciences Limited | 2 | tablet, film coated | Generic drugs (ANDA) | July 12, 2017 |
| Zydus Lifesciences Limited | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | May 16, 2013 |
| Armas Pharmaceuticals Inc. | 1 | injection, solution | Generic drugs (ANDA) | June 1, 2026 |
| Axsome Therapeutics, Inc. | 1 | tablet | New drug applications (NDA) | May 19, 2025 |
| Baxter Healthcare Corporation | 1 | injection | Generic drugs (ANDA) | January 19, 2023 |
| Bryant Ranch Prepack | 1 | spray | Generic drugs (ANDA) | November 16, 2021 |
| Caplin Steriles Limited | 1 | injection, solution | Generic drugs (ANDA) | September 28, 2024 |
| Currax Pharmaceuticals LLC | 1 | tablet, film coated | New drug applications (NDA) | April 25, 2008 |
| Currax Pharmaceuticals LLC DBA Cypress, Hawthorn, Macoven | 1 | tablet | Authorized generics (NDA) | May 14, 2015 |
| Dr. Reddy's Laboratories Inc. | 1 | injection | Generic drugs (ANDA) | April 20, 2023 |
| Florida Pharmaceutical Products, LLC | 1 | spray | Generic drugs (ANDA) | May 15, 2021 |
| Fresenius Kabi USA, LLC | 1 | injection | Generic drugs (ANDA) | April 12, 2011 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection | Generic drugs (ANDA) | September 16, 2013 |
| Ingenus Pharmaceuticals, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | July 22, 2022 |
| Leading Pharma, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | February 28, 2026 |
| NorthStar RxLLC | 1 | injection | Generic drugs (ANDA) | June 13, 2023 |
| Quality Care Products, LLC | 1 | tablet | Generic drugs (ANDA) | February 4, 2021 |
| Somerset Therapeutics, LLC | 1 | injection, solution | Generic drugs (ANDA) | October 25, 2021 |
| Strides Pharma Science Limited | 1 | injection, solution | Generic drugs (ANDA) | March 16, 2026 |
| Upsher-Smith Laboratories, LLC | 1 | spray | New drug applications (NDA) | July 8, 2019 |
| Xellia Pharmaceuticals USA LLC | 1 | injection | Generic drugs (ANDA) | January 1, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 94 | 33.5% |
| Tablet | 90 | 32% |
| Tablet, orally disintegrating | 44 | 15.7% |
| Injection | 18 | 6.4% |
| Spray | 16 | 5.7% |
| Injection, solution | 13 | 4.6% |
| Film | 3 | 1.1% |
| Spray, metered | 2 | 0.7% |
| Solution | 1 | 0.4% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.